February 11, 2026 07:07 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bangladesh poll manifestos mirror India’s welfare schemes as BNP, Jamaat bet big on women, freebies | Drama ends: Pakistan makes U-turn on India boycott, to play T20 World Cup clash as per schedule | ‘Won’t allow any impediment in SIR’: Supreme Court pulls up Mamata govt over delay in sharing officers’ details | India-US trade deal: ‘Negotiations always two-way’, says Amul MD amid farmers’ concerns | Khamenei breaks 37-year-old ritual for first time amid escalating Iran-US tensions | India must push for energy independence amid global uncertainty: Vedanta chairman Anil Agarwal | Kanpur horror: Lamborghini driven by businessman’s son rams vehicles, injures six | ‘Namaste Trump beat Howdy Modi’: Congress slams PM Over India-US trade deal | Historic India-US trade pact: Tariffs cut, $500B market opportunity unlocked! | Big call from RBI: Repo rate stays at 5.25%, neutral stance continues
Canada
Image credit: Wikimedia Commons

Health Canada approves Moderna’s updated COVID-19 vaccine for Omicron variant

| @indiablooms | Sep 03, 2022, at 05:03 am

Toronto/IBNS: Moderna’s updated COVID-19 vaccine targeting the Omicron variant has been formally approved by Health Canada.

This vaccine has been approved for use in adults and will become the first COVID-19 vaccine available in Canada that targets Omicron in addition to the original strain of the coronavirus.

Health Canada said in a decision summary made public Thursday, that the new vaccine shows “significantly higher responses” to the Omicron BA.1 virus in comparison to Moderna’s original coronavirus vaccine, officially branded as Spikevax.

Although the updated vaccine was developed to target the Omicron BA.1 variant, clinical trials, says Health Canada suggest the new vaccine still shows a stronger immune response against the more recent mutations of Omicron — BA.4 and BA.5 — which are now dominant.

According to recommendations of the National Advisory Committee on Immunization (NACI) the updated vaccine should be offered to adults who are recommended to receive a fall booster dose.

NACI says that the vaccine could also be offered to adolescents between 12 and 17 with “moderately to severely immunocompromising conditions” and those who have elevated social risk factors.

(Reporting by Asha Bajaj)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.